Alembic Pharma
TRENDING NOW
Alembic Pharma Shares Drop To 52-Week Low On Taking Impairment Charge For Gujarat Plants
Fri, Mar 03, 2023
Shares of Alembic Pharmaceuticals Ltd. declined to their 52-week low after the company said it will take a Rs 1,150.43 crore impairment charge for three facilities in Gujarat. How is the financial status of Alembic Pharma? Know the complete details from Nupur.
More >
Q4 Results 2022: Jindal Stainless, Alembic Pharma, Mahindra Holidays announce March quarter results; here are key highlights
Mon, May 02, 2022
Q4 Results 2022: Companies which declared their results included Jindal Stainless Ltd, Alembic Pharma, Mahindra Holidays and TARC Ltd. Here are key highlights of the results
More >
Alembic Pharmaceuticals' joint venture Aleor gets USFDA approval to market Mupirocin cream
Wed, Nov 17, 2021
The approved abbreviated new drug application (ANDA) for Mupirocin cream is therapeutically equivalent to the reference listed drug product (RLD), Bactroban cream (2 per cent) of SmithKline Beecham (Cork) Ltd, Ireland, the company said.
More >
Alembic Pharmaceuticals Ltd share price slumps 11% amid disappointing Q1 numbers – details cited here for stock investors
Tue, Jul 27, 2021
Amid the disappointing first-quarter numbers, the shares of Alembic Pharmaceuticals declined over 11 per cent to Rs 808 on the BSE in intraday trade on Tuesday. The pharma company on Monday reported weak numbers, with consolidated profit dipped almost half a year-on-year (YoY) basis.
More >
ICICI Securities downgrades Alembic Pharma stock to HOLD, target price Rs 984
Wed, May 05, 2021
ICICI Securities said that Alembic Pharma reported Q4FY21 performance largely in line with estimates, though EBITDA margin was higher due to lower operating costs. Revenue in US was below expectation at US$63mn due to competitive pressure and the management indicated the US revenue quarterly base would be between US $55 - $60mn
More >
